06 Nov Join Our EU FMD Webinar: How to Develop a Robust Plan with Rapid Implementation
SERIALISATION EXPERTS OPTEL, BE4WARD AND VERIFY BRAND TO OFFER WEBINAR TO PREPARE PHARMA ORGANIZATIONS FOR EU FMD
MINNEAPOLIS – November 6, 2017 – The countdown to EU Falsified Medicines Directive (EU FMD) compliance is underway. With fewer than two years until the serialisation compliance deadline takes effect, industry serialization leaders, Optel Group, Be4ward and Verify Brand, will present a free 60-minute webinar November 14 for pharmaceutical organizations that must comply with EU FMD. The webinar, “How to Develop a Robust Plan with Rapid Implementation,” will provide pharmaceutical companies with the tools to develop a comprehensive strategy and implementation plan in advance of the February 9, 2019 EU FMD compliance deadline.
With 32 countries across Europe being affected by the EU FMD legislation, this webinar will help pharma companies avoid supply interruption, identify key solutions tailored specifically for rapid implementation, and implement EU FMD solutions with minimal impact to organizational resources.
The webinar presenters are all experts in the field of serialization: Jean-Pierre Allard, Chief Technology Officer at Optel Group; Stephen McIndoe, Be4ward serialisation practice vice president; and Dhermita Desai, Verify Brand senior project manager. Webinar topics will include:
- an overview of the EU FMD legislation — where we are now, the implications of EU FMD on an organization, and complex implementation scenarios pharma organizations may encounter;
- the key elements of successful EU FMD planning and execution;
- how to make sure that your packaging meets EU FMD product tamper evidence requirements;
- how to ensure that your serialization software seamlessly connects to your trading partners and delivers all your EU FMD requirements (e.g., configuration and validation).
For more information about the webinar and to register, go here.
About OPTEL GROUP
Now a Certified B Corporation, OPTEL is a leading multinational provider of traceability systems, and its mission is to use its innovative technologies to create a better world through responsible capitalism. The company’s renowned solutions ensure the quality of consumer health products and help stop counterfeiting of pharmaceuticals and medical devices throughout the world. OPTEL is also adapting its technologies to create efficiencies in various other sectors ─ from health-related industries to smart manufacturing and more, all can benefit from global traceability. OPTEL’s expertise will allow diverse industries to measure, inspect, control and track a variety of elements to improve quality and make better use of resources. For more information, visit www.optelgroup.com/.
Be4ward is a niche consultancy company helping pharmaceutical, biotech and medical device companies and their supply base improve their serialisation, labelling and artwork capabilities. We help clients define the most efficient business processes, organisation design and, being completely independent, help them select and implement the most appropriate service providers and IT systems to meet their needs. Be4ward helps these companies improve patient safety and drive additional value from their product range. For more information, visit www.be4ward.com/.
About Verify Brand
Since 2004, Verify Brand has helped organizations secure revenue streams and safeguard brand reputation by eliminating fraudulent activity along the supply chain and in the end-user market. The company’s leading serialization and traceability software, The Verify Platform, empowers the world’s best-known B2C and B2B brands to gain visibility into supply chains and partner networks, achieve global compliance, operationalize business data and drive brand value.
Michele Arcand, Optel Group
Stephen McIndoe, Be4ward
+44 (0) 800 098 8795
Barb Brynstad, Verify Brand